Balchem (BL9B) Financial Statements
Balchem Financial Overview
Balchem's market cap is currently $4.45B. The company's EPS TTM is $5.34; its P/E ratio is 31.83; and it has a dividend yield of 0.55%. Balchem is estimated to report earnings on February 19, 2027, and the estimated EPS forecast is $1.16. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.04B | $ 953.68M | $ 922.44M | $ 942.36M | $ 799.02M |
| Gross Profit | $ 370.63M | $ 336.21M | $ 302.06M | $ 280.45M | $ 243.17M |
| Operating Income | $ 218.33M | $ 182.91M | $ 159.19M | $ 145.19M | $ 127.50M |
| EBITDA | $ 254.94M | $ 230.95M | $ 214.81M | $ 195.87M | $ 176.57M |
| Net Income | $ 154.84M | $ 128.47M | $ 108.54M | $ 105.37M | $ 96.10M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 74.57M | $ 49.52M | $ 64.45M | $ 66.56M | $ 103.24M |
| Total Assets | $ 1.71B | $ 1.58B | $ 1.60B | $ 1.62B | $ 1.20B |
| Total Debt | $ 192.01M | $ 208.04M | $ 330.33M | $ 460.61M | $ 118.04M |
| Net Debt | $ 117.44M | $ 158.53M | $ 265.89M | $ 394.05M | $ 14.80M |
| Total Liabilities | $ 450.15M | $ 425.46M | $ 543.23M | $ 686.23M | $ 322.31M |
| Stockholders' Equity | $ 1.26B | $ 1.15B | $ 1.05B | $ 938.28M | $ 877.01M |
| Cash Flow | |||||
| Free Cash Flow | $ 173.07M | $ 146.34M | $ 145.87M | $ 88.25M | $ 123.06M |
| Operating Cash Flow | $ 216.56M | $ 182.00M | $ 183.76M | $ 138.54M | $ 160.51M |
| Investing Cash Flow | $ -43.89M | $ -59.74M | $ -34.81M | $ -416.01M | $ -35.30M |
| Financing Cash Flow | $ -152.81M | $ -133.81M | $ -153.32M | $ 246.68M | $ -102.18M |
Currency in USD